Marker Therapeutics, Inc.

Monthly Archives: March 2020

Marker Therapeutics Reports Full Year 2019 Operating and Financial Results

Marker Therapeutics today provided a corporate update and reported financial results for the full year ended December 31, 2019.

Read More

Marker Therapeutics and Aspire Capital Enter into a Common Stock Purchase Agreement for up to $30 million

Marker Therapeutics today announced that the Company has entered into a Common Stock Purchase Agreement of up to $30 million with Aspire Capital Fund, LLC, a Chicago-based institutional investor and long-term Marker shareholder.

Read More